BPC-157 Arginate , also referred to as Pentadeca Arginate Peptide (PDA) , is a peptide modification of the naturally occurring BPC-157 found in human gastric juice
Preclinical studies showed no adverse effects across several organ systems including liver, spleen, lung, kidney, brain, thymus, prostate, and ovaries in studies up to 6 weeks
Studies on animals have shown that it can lessen inflammation and hasten the healing of stomach ulcers
Novo Nordisk A/S : It develops innovative treatments for obesity, cardiovascular disease, diabetes, and rare blood or endocrine disorders, with a solid pipeline including Phase 1-3 trials for semaglutide, amylin analogues, as well as siRNA